Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Ostadal

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Trials|May 27, 2010
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)Petr Ostadal, David Alan, Jiri Vejvoda, et al.
Lancet (London, England)|August 29, 2023
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trialsUwe Zeymer, Anne Freund, Matthias Hochadel, et al.
Plos One|July 30, 2021
Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fractionPetr Lokaj, Jindrich Spinar, Lenka Spinarova, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2022
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trialPetr Ostadal, Philippe Gabriel Steg, Yann Poulouin, et al.
European Journal of Internal Medicine|April 22, 2020
Heart rate as an independent predictor of long term mortality of acute heart failure patients in sinus rhythm according to their ejection fraction: data from the AHEAD registryJiri Jarkovsky, Jindrich Spinar, Benoit Tyl, et al.
ESC Heart Failure|February 21, 2017
Worse prognosis of real-world patients with acute heart failure from the Czech AHEAD registry in comparison to patients from the RELAX-AHF trialJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.
International Journal of Cardiology|September 21, 2015
AHEAD score--Long-term risk classification in acute heart failureJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.
Journal of the American College of Cardiology|November 12, 2013
ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trialIvo Bernat, David Horak, Josef Stasek, et al.
Pharmacological Research|February 19, 2021
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)Maciej Banach, Peter E Penson, Michal Vrablik, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2025
Clinical characteristics, management and predictors of mortality: results from national prospective cardiogenic shock registry (CZECH-SHOCK)Michal Pazdernik, Petr Ostadal, Jiri Seiner, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Trials|May 27, 2010
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)Petr Ostadal, David Alan, Jiri Vejvoda, et al.
Lancet (London, England)|August 29, 2023
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trialsUwe Zeymer, Anne Freund, Matthias Hochadel, et al.
Plos One|July 30, 2021
Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fractionPetr Lokaj, Jindrich Spinar, Lenka Spinarova, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2022
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trialPetr Ostadal, Philippe Gabriel Steg, Yann Poulouin, et al.
European Journal of Internal Medicine|April 22, 2020
Heart rate as an independent predictor of long term mortality of acute heart failure patients in sinus rhythm according to their ejection fraction: data from the AHEAD registryJiri Jarkovsky, Jindrich Spinar, Benoit Tyl, et al.
ESC Heart Failure|February 21, 2017
Worse prognosis of real-world patients with acute heart failure from the Czech AHEAD registry in comparison to patients from the RELAX-AHF trialJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.
International Journal of Cardiology|September 21, 2015
AHEAD score--Long-term risk classification in acute heart failureJindrich Spinar, Jiri Jarkovsky, Lenka Spinarova, et al.
Journal of the American College of Cardiology|November 12, 2013
ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trialIvo Bernat, David Horak, Josef Stasek, et al.
Pharmacological Research|February 19, 2021
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)Maciej Banach, Peter E Penson, Michal Vrablik, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2025
Clinical characteristics, management and predictors of mortality: results from national prospective cardiogenic shock registry (CZECH-SHOCK)Michal Pazdernik, Petr Ostadal, Jiri Seiner, et al.
Pageof 8